NanoViricides Inc. (NNVC)

[crashco]

FluCide is ready for Tox and Human trials in 2013. Production volumes sufficient for Tox are in progress. Tox studies will be completed in q1-2 of 2013. Human tolerance for PEG has been established and all indicators point to successful Toxicity test results.
Australian regulatory process, the consulting firm hired and the timing of flu season down under suit the trajectory for a q3 human trial. Flu mitigation trials are short-lived. Results will be in by close of 2013.
Construction Permits are meandering through the bureaucratic process in CT. Nanoviricides in-house production or contracted third party production will be impacted by the timing. The outcome will impact cost and post FCC approval market readiness. The realities of in-house production and going it alone will favor a big-Pharma partnership. This outcome too will occur in late 2013.